News | RSNA | December 05, 2022

During RSNA 2022, three leaders in the field of Radiology AI announced they have formed a novel AI Safety initiative to strengthen the continued AI performance in clinical workflows, make AI algorithm use in clinical routines safer, and help make management and retraining easier. 

Dr. Martin Willemink, MD PhD, CEO Segmed, John Moulden, CCO deepc, Dr. Anna Tidstam, CTO, deepc, and Erik Duhaime, CEO Centaur Labs. (PRNewsfoto/Deepc)

Dr. Martin Willemink, MD PhD, CEO Segmed, John Moulden, CCO deepc, Dr. Anna Tidstam, CTO, deepc, and Erik Duhaime, CEO Centaur Labs. (PRNewsfoto/Deepc) 

 


December 5, 2022 —  With AI becoming an integral part of clinical radiology workflows, the data used to develop AI algorithms is ever essential. An identified industry challenge is ensuring post-market surveillance of AI at scale, providing a foundation for the continued clinical safety and improvement of algorithms before and after clinical deployment. AI algorithms already need to meet high-performance standards for clearance by notified bodies such as the FDA

However, in some clinical scenarios, the performance of an AI algorithm may not meet expectations or degrade over time, e.g. due to different target patient populations or new scanner types. To identify such effects immediately, it is crucial to assess the performance of AI before and during its deployment in routine clinical use. In such cases, AI algorithms can then be re-trained on broader datasets, reflecting the target population, and making them more robust and safe. To address this need, deepc, Centaur Labs, and Segmed have joined forces and started a Radiology AI Safety Initiative to strengthen the continued AI performance in clinical workflows. 

Three leaders in the field of Radiology AI have formed a novel AI Safety initiative to make AI algorithm use in clinical routines safer, as well as management and retraining easier. 

MedTech company deepc with its leading radiology AI platform deepcOS offers radiologists access to a myriad of regulatory-cleared AI solutions from their globally leading partner network.
Segmed provides secured, de-identified medical data, and Centaur Labs a labeling solution for such data.Collaborating with its AI Partners, deepc helps AI applications fulfill the highest safety and performance standards.
Customers that use deepcOS commonly seek validation and benchmarking assistance to identify the optimal performance of algorithms and pre-launch safety checks, offering surety of selection meeting the specific needs of the clinical environment.
Segmed's self-serve data platform Insight allows AI developers to build cohorts of de-identified and structured data that are readily available for training, testing, and validation of AI algorithms.
Together with Centaur Labs, medical labeling services can be provided for given clinical indication fields to ensure safe operations of AI engines on specific customer data prior to deployment. 

The companies are developing a joint offering. AI vendors will be able to perform real-time post-market surveillance via the deepcOS platform and identify when an AI model is performing suboptimally over time, a phenomenon that is often regarded as 'AI drift'. This may be caused by a shifting patient population or new scanner types, for instance. deepc will avail this precise information to AI vendor partners and offer on-demand access to data that is anonymized and cleared for AI R&D through Segmed's data platform, and annotated by Centaur Lab's scalable data annotation platform. This data can be used to retrain the AI algorithm, improve performance, robustness, and clinical AI safety. Obtaining diverse, relevant data and labeling this data are two of the biggest bottlenecks in AI pipelines, solved by deepc's partners Segmed and Centaur Labs. 

"An outstanding effort of our companies leads to improved clinical AI safety, eventually leading to better clinical outcomes and increased patient safety. We are very proud to be leading this very important initiative in the industry", says deepc's Co-Founder and CEO Dr. Franz Pfister. 

For more information: https://www.deepc.ai/ 

Find more RSNA22 coverage here  


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | HIMSS

February 29, 2024 — The Healthcare Information Management Systems Society, HIMSS, recently announced it HIMSS 2024 ...

Time February 29, 2024
arrow
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Time February 28, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 28, 2024 — Royal Philips, a global leader in health technology, today announced a significant milestone as it ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 28, 2024 — DeepHealth, one of the leading providers of radiology informatics and AI solutions, and Incepto ...

Time February 28, 2024
arrow
News | Radiology Business

February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of ...

Time February 28, 2024
arrow
News | Women's Health

February 27, 2024 — Hologic, Inc. continues to deliver on its commitment to advancing women’s health by unveiling new ...

Time February 27, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
Subscribe Now